Ocular Therapeutix (OCUL) Preferred Stock Liabilities (2013 - 2014)
Ocular Therapeutix (OCUL) recorded Preferred Stock Liabilities of $74.36 million in Q2 2014.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Preferred Stock Liabilities (2013 - 2014) Analysis & Trends
At the end of FY2013, Ocular Therapeutix reported Preferred Stock Liabilities of $74.34 million.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | - |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | - |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | - |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | - |
API Access
Ocular Therapeutix Preferred Stock Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-stock-liabilities", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();